Abstract
The way a membrane antigen enters the immune system is a feature of critical importance on which the efficient induction of distinct reaction patterns depends (Mitchison, 1979). This is especially true when we are dealing with proliferating tumor cells (Forni et al., 1983).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Berendt, M. T., and North, R. J., 1980, T-cell mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor. J. Exp. Med., 151: 169.
Carbone, G., Colombo, M., P., Sensi, M. L., Cernuschi, A., and Parmiani, 1983, G., In vitro detection of cell mediated immunity to individual tumor specific antigens of chemically induced BALB/c fibrosarcomas, Int. J. Cancer, 31: 483.
Dennert, G., and DeRose, M., 1976, Continuously proliferating T killer cells specific for H-2b targets: selection and characterization, J. Immunol., 116: 1601.
Dennert, G., Yogeeswaran, G., and Yamagata, S., 1981, Cloned cell lines with natural killer activity. J. Exp. Med., 153:545.
Djeu, J. Y., Huang, K. Y., and Herberman, R. B., 1980 Augmentation of mouse natural killer activity and induction of interferon by tumor cells in vivo. J. Exp. Med., 151: 781.
Djeu, J. Y., Timonen, T., and Herberman, R. B., 1982, Production of interferon by human natural killer cells in response to mitogens, viruses, and bacteria, in “NK Cells and Other Natural Effector Cells”, R. B. Herberman, ed., Academic Press, New York.
Domzig, W., and Stadler, B. M., 1982, The relation between human natural cells and interleukin 2, in “NK Cells and Other Natural Effector Cells”, R. B. Herberman, ed., Academic Press, New York.
Donohue, J. H., and Rosenberg, S.A., 1983, The fate of IL 2 after in vivo administration, J. Immunol., 130: 2203.
Engers, H. D., Sorenson, G. D., Terres, G., Howath, C., and Brunner, K.T., 1982, Functional activity in vivo of effector cell populations. I. Anti-tumor activity exhibited by allogeneic mixed leukocyte culture cells. J. Immunol., 129: 1292.
Farrar, J. J., Fuller-Farrar, J., Simon, P. L., Hilfiker, M., Stadler, B. M., and Farrar W. L., 1980, Thymoma production of T cell growth factor (interleukin 2), J. Immunol., 125: 2555.
Forni, G., and Giovarelli, M., 1984, In vitro reeducated T helper cells from sarcoma-bearing mice inhibit sarcoma growth in vivo, J. Immunol., 132: 156.
Forni, G., Shevach, E. M., and Green, I., 1976, Mutant lines of guinea pig L2C leukemia. I. Deletion of Ia alloantigens is associated with a loss in immunogenicity of tumor associated transplantation antigens, J. Exp. Med., 143: 1067.
Forni, G., Varesio, L., Giovarelli, M., and Cavallo, G., 1979, Dynamic state of spontaneous immune reactivity towards a mammary adenocarcinoma, in: “Current Trends in Tumor Immunology”, S. Ferrone, S. Gorini, R. B. Herberman and R. A. Reisfeld, eds., Garland STPM Press, New York.
Forni, G., Landolfo, S., Giovarelli, M., Whitmore, A. C., and R. B. Herberman, 1982, Immune recognition of tumor cells in vivo. I. Role of H-2 gene products in T lymphocyte activation against minor histocompatibility antigens displayed by adenocarcinoma cells, Eur. J. Immunol., 12: 664.
Forni, G., Giovarelli, M., Sarzotti, M., and Whitmore, A. C., 1983, RSV-induced tumors in mice. II. Contribution of H-2 and non-H-2 alloantigen barriers to tumor immunogenicity in vivo, J. Immunogenetics, 10: 209.
Gerson, J. M., Varesio, L., and Herberman,R.B., 1981, Systemic and in situ natural killer activity and suppressor cell activities in mice bearing progressively growing murine sarcoma virus induced tumors, Int.J. Cancer, 27: 243.
Giovarelli, M., Landolfo, S., Whitmore, A. C., and Forni, G., 1982a, Rous sarcoma virus-induced tumors in mice. I. Macrophage mediated natural cytotoxicity, Eur. J. Cancer Clin. Oncol., 18: 307.
Giovarelli, M., Landolfo, S., Scher, I., and Forni, G., 1982b, Distinct alloantigens trigger proliferative and non proliferative T lymphocyte activation in CBA/N, CBA/J, and C3H mice, Transplantation, 33: 260.
Grimm, E. A., and Rosenberg, S. A., 1983, The human lymphokine activated killer cell phenomenon, The lymphokines, 9: 435
Herberman, R. B., 1977, Existence of tumor immunity in man, in “Mechanisms of Tumor Immunity”, I. Green, S. Cohen, R. T. McCluskey, eds., J. Wiley & Sons, New York.
Herberman, R. B., ed., 1982, “NK Cells and Other Natural Effector Cells”, Academic Press, New York.
Herberman, R. B., 1984, Immune surveillance hypothesis: Updated formulation and possible effector mechanisms, in “Immunology 1983”, T. Tada, ed., Academic Press, New York, (1984).
Kasahara, K., Djeu, J. Y., Dougherty, S. F., and Oppenheim, J. J., 1983, Capacity of human large granular lymphocytes to produce multiple lymphokines: Interleukin 2, interferon, and colony stimulating factor, J. Immunol., 131: 2379.
Mitchison, N. A., Regulation of the response to cell surface antigens, in: “Current Trends in Tumor Immunology”, S. Ferrone, S. Gorini, R. B. Herberman and R. A. Reisfeld, eds., Garland STPM Press, New York (1979).
Nanni, P., De Giovanni, C., Lollini, P. L., Nicoletti, G., and Prodi, G., 1983, TS/A: a new metastatizating cell line originated from a BALB/c spontaneous mammary adenocarcinoma, Clin. Expl. Metastasis, 1: 373.
Sarzotti, M., Giovarelli, M., and Forni, G., 1982, Interferon production in mixed cultures of murine leukocytes and syngeneic L1210 leukemia cells, Boll. Ist. Sieroter. Mil., 147:1314
Schrier, P.I., Bernards, R., Vaessen, R. T. M. J., Houweling, A., and van der Eb, A.J., 1983, Expression of class I major histocompatibility antigen switched off by highly oncogenic adenovirus 12 in transformed rat cells, Nature, 305: 771.
Trinchieri, G., and Santoli, D., 1978, Anti viral activity induced by culturing lymphocytes with tumor derived or virus transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis, J. Exp. Med., 147: 1314.
Varesio, L., Giovarelli, M., Landolfo, S., and Forni, G., 1979, Suppression of proliferative response and lymphokine release during the progression of a spontaneous tumor, Cancer Res., 39: 4983.
Varesio, L., Landolfo, S., Giovarelli, M., and Forni, G., 1980, The macrophage as the social interconnection within the immune system, Dev. Comp. Immunol., 4: 11.
Wagner, H., Hard, C., Heeg, K, Rollinghoff, M., and Pfizenmaier, K., 1980, T cell derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu mice, Nature, 284: 278.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Forni, G., Giovarelli, M., Sola, S.C., Santoni, A. (1984). IL-2 and Lymphocytes from Tumor Bearing Mice: A Combinatory Immunotherapy of Tumors. In: Aaronson, S.A., Frati, L., Verna, R. (eds) Genetic and Phenotypic Markers of Tumors. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4856-6_17
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4856-6_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4858-0
Online ISBN: 978-1-4684-4856-6
eBook Packages: Springer Book Archive